From left: Pow Pocket Sdn Bhd Senior Advisor Kuhan Arunasalam, Pow Pocket managing director Russell Walter Boyd, Hong Seng Consolidated Bhd non-executive chairman Datuk Seri Dr Chen Chaw Min, Hong Seng group managing director Datuk Seri Teoh Hai Hin and Hong Seng executive director Lester Chin.
KUALA LUMPUR: Hong Seng Consolidated Bhd
’s unit HS Bio Sdn Bhd is buying a 51% stake in Pow Pocket Sdn Bhd for RM200mil cash consideration which plans to roll out a nationwide end-to-end private Covid-19 vaccine programme.
In a statement on Friday, it said Pow Pocket’s programme to be known as “Immunise”, is an open and inclusive platform to capture the demand for booster and juvenile vaccination shots in the country.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
